GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Asset Impairment Charge

U2Bio Co (XKRX:221800) Asset Impairment Charge : ₩0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Asset Impairment Charge?

U2Bio Co's Asset Impairment Charge for the six months ended in Dec. 2023 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.


U2Bio Co Asset Impairment Charge Historical Data

The historical data trend for U2Bio Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Asset Impairment Charge Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only - - - - -

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Asset Impairment Charge - - - -

U2Bio Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩0 Mil.


U2Bio Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines